Literature DB >> 22129321

Propranolol safety profile in children.

Mortada El-Shabrawi1, Fetouh Hassanin.   

Abstract

Data regarding the use of propranolol in pediatrics are limited despite its widespread use in adults. Since 1984, Propranolol has been used for the prevention of portal hypertensive hemorrhage in pediatric patients. Recently it has been also used for the management of hemangiomas in addition to other indications. The purpose of this review is to evaluate safety and efficacy of propranolol use in the pediatric population, highlighting the most important reported side effects, warnings and precautions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129321     DOI: 10.2174/157488611798280889

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  3 in total

1.  A Novel Voltametric Measurements of Beta Blocker Drug Propranolol on Glassy Carbon Electrode Modified with Carbon Black Nanoparticles.

Authors:  Izabela Bargiel; Joanna Smajdor; Anna Górska; Beata Paczosa-Bator; Robert Piech
Journal:  Materials (Basel)       Date:  2021-12-09       Impact factor: 3.623

2.  Propranolol: A 50-Year Historical Perspective.

Authors:  A V Srinivasan
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383

3.  The therapeutic efficacy of propranolol in children with recurrent primary epistaxis.

Authors:  Bojko Bjelakovic; Mila Bojanovic; Stevo Lukic; Ljiljana Saranac; Vladislav Vukomanovic; Sergej Prijic; Nikola Zivkovic; Dusica Randjelovic
Journal:  Drug Des Devel Ther       Date:  2013-03-01       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.